MedPath

Eisai Korea Inc.

Eisai Korea Inc. logo
🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

Phase 4
Completed
Conditions
Epilepsy
Interventions
First Posted Date
2005-09-12
Last Posted Date
2009-09-02
Lead Sponsor
Eisai Korea Inc.
Target Recruit Count
140
Registration Number
NCT00154076
Locations
🇰🇷

Daegu Catholic University Medical Center, Daegu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath